GAM501

· Tissue Repair Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GAM501, covering 2010-02-10 to 2010-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2b Study of GAM501 in the Treatment of Diabetic Ulcers of the Lower Extremities [Phase 2]